Registered entities
Pharmathene Inc.
Reg. No. 202726770United States
Innovation
7 patent families (4 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing; filing pace dormant.
Developing anthrax vaccine designed to protect against inhalational anthrax.
7 patent families (4 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing; filing pace dormant.